Oncology & Cancer

Anti-inflammatory strategy stops aggressive childhood cancer

Researchers at Karolinska Institutet and Karolinska University Hospital have discovered that an anti-inflammatory drug candidate inhibiting the prostaglandin E2 producing enzyme mPGES-1 in the tumour stroma reduces tumour ...

Oncology & Cancer

Better equipped in the fight against lung cancer

Lung cancer is the third-most common type of cancer in Germany, affecting both men and women. However, immunotherapies are successful in only 20 percent of cases. Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg ...

Health

New health benefits discovered in berry pigment

Naturally occurring pigments in berries, also known as anthocyanins, increase the function of the sirtuin 6 enzyme in cancer cells, a new study from the University of Eastern Finland shows. The regulation of this enzyme could ...

Oncology & Cancer

New weakness found in most common childhood malignant brain tumor

A new weakness found in medulloblastoma, the most common form of childhood brain tumour, could lead to more personalised medicine and improved treatment for some patients, according to an early study by Queen Mary University ...

page 5 from 15